Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Braster has developed and commercialized a proprietary device for early breast cancer detection using liquid crystal contact thermography. The system supports both home-based self-examination (Braster System) and professional use in healthcare settings (Braster Pro). The technology has CE marking and TUV NORD certification for quality management systems. Clinical studies have confirmed the effectiveness of the device as an adjunct to standard screening methods such as ultrasound and mammography[1][2][3][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Braster.